Agudelo CI, Castaneda-Orjuela C, Brandileone MC, et al. The direct effect of pneumococcal conjugate vaccines on invasive pneumococcal disease in children in the Latin American and Caribbean region (SIREVA 2006–17): a multicentre, retrospective observational study. Lancet Infect Dis 2020 (published online Sep 25)
Albin OR, Kaye KS. Utility of radiographic keyword abstraction for identification of misdiagnosed pneumonia. Infect Control Hosp Epidemiol 2021 (Concise communication) (published online Apr 29)
Appelt S, Jacob D, Rohleder AM, et al. Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017. Eurosurveill 2020 Sep 10;26(36)
Arias-Fernandez L, Gil-Prieto R, Gil-de-Miguel A. Incidence, mortality, and lethality of hospitalizations for community-acquired pneumonia with comorbid cardiovascular disease in Spain (1997–2015). BMC Infect Dis 2020 (published online Jul 6)
Aris P, Robatjazi S, Nikkhahi F, et al. Molecular mechanisms and prevalence of colistin resistance of Klebsiella pneumoniae in the Middle East region: a review over five last years. J Glob Antimicrob Resist 2020 (published online Jun 23)
Baron SA, Cassir N, Hamel M, et al. Risk factors for acquisition of colistin-resistant Klebsiella pneumoniae and expansion of a colistin-resistant ST307 epidemic clone in hospitals in Marseille, France, 2014 to 2017. Eurosurveill 2021 May 27;26(21)
Ben-Shimol S, Givon-Lavi N, Kotler L, et al. Post–13-valent pneumococcal conjugate vaccine dynamics in young children of serotypes included in candidate extended-spectrum conjugate vaccines. Emerg Infect Dis 2021 Jan;27(1)
Berry I, Tuite AR, Salomon A, et al. Association of influenza activity and environmental conditions with the risk of invasive pneumococcal disease. JAMA Netw Open 2020 Jul 13;3(7):e2010167
Camara J, Grau I, Gonzalez-Diaz A, et al. A historical perspective of MDR invasive pneumococcal disease in Spanish adults. J Antimicrob Chemother 2020 (published online Nov 30)
Cao T, Liu Y, Li Y, et al. A public health concern: emergence of carbapenem-resistant Klebsiella pneumoniae in a public transportation environment. J Antimicrob Chemother 2020 (published online Jul 4)
Carey E, Blankenhorn R, Chen P, et al. Non-ventilator associated hospital acquired pneumonia incidence and health outcomes among U.S. veterans from 2016-2020. Am J Infect Control 2021 (published online Jun 8)
Carr OJ, Vilivong K, Bounvilay L, et al. Nasopharyngeal pneumococcal colonization Density is associated with severe pneumonia in young children in the Lao PDR. J Infect Dis 2021 (published online May 11)
Chan T, Tay MZ, Kyaw WM, et al. Epidemiology, vaccine effectiveness, and risk factors for mortality for pneumococcal disease among hospitalised adults in Singapore: a case-control study. BMC Infect Dis 2020 Jun 17;20 (423)
Chapman R, Sutton K, Dillon-Murphy D, et al. Ten year public health impact of 13-valent pneumococcal conjugate vaccination in infants: a modelling analysis. Vaccine 2020 (published online Sep 8)
Chen D, Ye Z, Pi Z, et al. Cost-effectiveness of dual influenza and pneumococcal vaccination among the elderly in Shenzhen, China. Vaccine 2021 (published online Mar 20)
Chen FJ, Lauderdale TL, Huang WC, et al. Emergence of mcr-1, mcr-3, and mcr-8 in clinical Klebsiella pneumoniae isolates in Taiwan. Clin Microbiol Infect 2020 (published online Aug 6)
Chen H, Matsumoto H, Horita N, et al. Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis. Sci Rep 2021 Jun4;11:11865
Chen IR, Huanag PH, Wu PF, et al. Clinical characteristics and outcomes of 56 patients with pneumonia caused by carbapenem-resistant Klebsiella pneumoniae. J Glob Antimicrob Resist 2021 (published online May 4)
Chen L, Han X, Li YL, et al. The impact of early neuraminidase inhibitor therapy on clinical outcomes in patients hospitalised with influenza A-related pneumonia: a multicenter, retrospective study. BMC Infect Dis 2020 Aug 26;20(628)
Chen Z, Wu H, Jiang J, et al. Nutritional risk screening score as an independent predictor of nonventilator hospital-acquired pneumonia: a cohort study of 67,280 patients. BMC Infect Dis 2021 Apr 1;21:313
Clarke E, Bashorun A, Adigweme I, et al. Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in the Gambia: a phase 3, randomised, double-blind, non-inferiority trial. Lancet Infect Dis 2021 (published Jan 28)
